Please provide your email address to receive an email when new articles are posted on . Semaglutide positively affected renal fat mass, glomerular hemodynamics, inflammation and cortical fibrosis.
A phase 2 trial shows rilparencel improves annual eGFR slope, which suggests the cell therapy may preserve kidney function in patients with diabetic nephropathy. Rilparencel, an investigational renal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results